Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Tables)

v2.4.0.8
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2014
Segment Reporting [Abstract]  
Summary of segment information
Segment information is as follows (in thousands):
Balance Sheet Data:
As of March 31, 2014
 
Ligand
 
CyDex
 
Total
Total assets
$
40,969

 
$
64,502

 
$
105,471

 
 
 
 
 
 
 
As of December 31, 2013
 
Ligand
 
CyDex
 
Total
Total assets
$
38,408

 
$
66,305

 
$
104,713

 
 
 
 
 
 
Operating Data:
For the three months ended March 31, 2014
 
Ligand
 
CyDex
 
Total
Net revenues from external customers
$
6,791

 
$
9,167

 
$
15,958

Depreciation and amortization expense
66

 
602

 
668

Operating (loss) income
(71
)
 
5,171

 
5,100

Interest expense, net
248

 

 
248

Income tax expense from continuing operations
51

 
2

 
53

 
 
 
 
 
 
 
For the three months ended March 31, 2013
 
Ligand
 
CyDex
 
Total
Net revenues from external customers
$
6,237

 
$
5,414

 
$
11,651

Depreciation and amortization expense
59

 
611

 
670

Operating income
1,396

 
2,536

 
3,932

Interest expense, net
912

 

 
912

Income tax expense from continuing operations
66

 

 
66